These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9648829
1. Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Bernard C, Thibault C, Berthault MF, Magnan C, Saulnier C, Portha B, Pralong WF, Pénicaud L, Ktorza A. Diabetes; 1998 Jul; 47(7):1058-65. PubMed ID: 9648829 [Abstract] [Full Text] [Related]
2. Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats. Bernard C, Berthault MF, Saulnier C, Ktorza A. FASEB J; 1999 Jul; 13(10):1195-205. PubMed ID: 10385610 [Abstract] [Full Text] [Related]
3. Effect of prolonged in vivo glucose infusion on insulin secretion in rats with previous glucose intolerance. Thibault C, Laury MC, Bailbe D, Ktorza A, Portha B. Endocrinology; 1992 May; 130(5):2521-7. PubMed ID: 1572279 [Abstract] [Full Text] [Related]
4. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin. Portha B, Serradas P. Am J Med; 1991 Jun 24; 90(6A):15S-21S. PubMed ID: 1831320 [Abstract] [Full Text] [Related]
5. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments. Serradas P, Bailbé D, Blondel O, Portha B. Pancreas; 1991 Jan 24; 6(1):54-62. PubMed ID: 1994380 [Abstract] [Full Text] [Related]
6. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Tourrel C, Bailbé D, Meile MJ, Kergoat M, Portha B. Diabetes; 2001 Jul 24; 50(7):1562-70. PubMed ID: 11423477 [Abstract] [Full Text] [Related]
7. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. Diabetes; 1998 Feb 24; 47(2):224-9. PubMed ID: 9519717 [Abstract] [Full Text] [Related]
8. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Leahy JL, Weir GC. Diabetologia; 1991 Sep 24; 34(9):640-7. PubMed ID: 1955096 [Abstract] [Full Text] [Related]
10. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance]. Zeng CJ, Zhang L, Yang HX. Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 24; 45(9):658-63. PubMed ID: 21092544 [Abstract] [Full Text] [Related]
11. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model. Tsuji K, Taminato T, Usami M, Ishida H, Kitano N, Fukumoto H, Koh G, Kurose T, Yamada Y, Yano H. Metabolism; 1988 Nov 24; 37(11):1040-4. PubMed ID: 3054430 [Abstract] [Full Text] [Related]
12. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI. Diabetes; 1995 Dec 24; 44(12):1447-57. PubMed ID: 7589853 [Abstract] [Full Text] [Related]
13. Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat. Nicholson JM, Arany EJ, Hill DJ. Exp Biol Med (Maywood); 2010 Feb 24; 235(2):189-98. PubMed ID: 20404034 [Abstract] [Full Text] [Related]
14. Partial preservation of pancreatic beta-cells by vanadium: evidence for long-term amelioration of diabetes. Cam MC, Li WM, McNeill JH. Metabolism; 1997 Jul 24; 46(7):769-78. PubMed ID: 9225830 [Abstract] [Full Text] [Related]
15. In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period. Thibault C, Guettet C, Laury MC, N'Guyen JM, Tormo MA, Bailbé D, Portha B, Pénicaud L, Ktorza A. Diabetologia; 1993 Jul 24; 36(7):589-95. PubMed ID: 8359576 [Abstract] [Full Text] [Related]
16. Multiple abnormalities in insulin responses to nonglucose nutrients in neonatally streptozotocin diabetic rats. Grill V, Sako Y, Ostenson CG, Jalkanen P. Endocrinology; 1991 Apr 24; 128(4):2195-203. PubMed ID: 1706269 [Abstract] [Full Text] [Related]
17. [Protective effect of rosiglitazone sodium on islet beta-cell of STZ induced diabetic rats through JNK pathway]. Liu GY, An ZM. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May 24; 40(3):430-4. PubMed ID: 19626998 [Abstract] [Full Text] [Related]
18. Pancreatic hormones in streptozotocin-diabetic rats. Tomita T, Sasaki S, Doull V, Bunag R, Kimmel JR. Int J Pancreatol; 1986 Oct 24; 1(3-4):265-78. PubMed ID: 2890693 [Abstract] [Full Text] [Related]
19. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands. Grill V, Rundfeldt M. Diabetes; 1986 Jan 24; 35(1):44-51. PubMed ID: 2416619 [Abstract] [Full Text] [Related]
20. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production. Katakam AK, Chipitsyna G, Gong Q, Vancha AR, Gabbeta J, Arafat HA. J Endocrinol; 2005 Nov 24; 187(2):237-47. PubMed ID: 16293771 [Abstract] [Full Text] [Related] Page: [Next] [New Search]